Noom vs Ro
Neither Noom nor Ro has an FDA warning letter on record. No price lines up like for like. They share brand-name tirzepatide pen, but Ro's $299 covers the medication only, with a separate membership on top.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Noom / Ro
Noom
5.8/10
Ro
7.4/10
Neither Noom nor Ro pays us. Links to them earn nothing. Scores: Noom 5.8, Ro 7.4. How we are paid
What the record shows
- 01
Neither Noom nor Ro has an FDA warning letter on record.
- 02
Noom names no compounding pharmacy in our record. Ro sells brand-name medication only.
- 03
No price lines up like for like. They share brand-name tirzepatide pen, but Ro's $299 covers the medication only, with a separate membership on top.
- 04
Only Noom lists a price for compounded semaglutide injection. Only Ro lists a price for brand-name semaglutide pen, brand-name semaglutide pill and Foundayo (orforglipron) pill.
- 05
Ro lists all 50 states. Noom publishes no state list.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Noom
Ro
$349/mo
$4,188 a year
$299/mo
medication only, membership extra; not compared
$179/mo
$2,148 a year
$199/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
Read off each seller’s own pages. Noom: October 30, 2026. Ro: October 31, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Noom
5.8/10- Sells compounded semaglutide injection, which Ro does not price
- Names no compounding pharmacy
- Publishes no state list
The case for Ro
7.4/10- Sells brand-name semaglutide pen and brand-name semaglutide pill, which Noom does not price
- Price leaves out medication
- Lowest price covers the medication only, with a separate membership on top
Scores
Noom 5.8 · Ro 7.4 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Noom vs Ro: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Direct Meds7.1
From $249/mo
Visit site - SnagRx9.2
From $99/mo
Visit site - Embody9.3
From $79/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks